VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $31,010 | +15.2% | 1,000 | 0.0% | 0.01% | +14.3% |
Q3 2023 | $26,910 | -10.6% | 1,000 | 0.0% | 0.01% | -12.5% |
Q2 2023 | $30,110 | -6.9% | 1,000 | 0.0% | 0.01% | -11.1% |
Q1 2023 | $32,350 | +12.9% | 1,000 | 0.0% | 0.01% | +12.5% |
Q4 2022 | $28,660 | +19.4% | 1,000 | 0.0% | 0.01% | +14.3% |
Q3 2022 | $24,000 | -11.1% | 1,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $27,000 | -28.9% | 1,000 | 0.0% | 0.01% | -12.5% |
Q1 2022 | $38,000 | +46.2% | 1,000 | 0.0% | 0.01% | +33.3% |
Q3 2019 | $26,000 | +4.0% | 1,000 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $25,000 | +19.0% | 1,000 | 0.0% | 0.01% | +20.0% |
Q1 2019 | $21,000 | 0.0% | 1,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $21,000 | +16.7% | 1,000 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $18,000 | -18.2% | 1,000 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $22,000 | +4.8% | 1,000 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $21,000 | -8.7% | 1,000 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $23,000 | +4.5% | 1,000 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $22,000 | -4.3% | 1,000 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $23,000 | +4.5% | 1,000 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $22,000 | +10.0% | 1,000 | 0.0% | 0.01% | +20.0% |
Q4 2016 | $20,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |